Lessons from Lynch syndrome: A tumor biology-based approach to familial colorectal cancer

Future Oncology

Volumn 6, Issue 4, 2010, Pages 539-549

  Buchanan, Daniel D ^a   Roberts, Aedan ^a   Walsh, Michael D ^a   Parry, Susan ^b   Young, Joanne P ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b MIDDLEMORE HOSPITAL   (New Zealand)

Author keywords

Familial serrated neoplasia; Hyperplastic polyposis; Lynch syndrome; MUTYH associated polyposis; Somatic BRAF mutation

Indexed keywords

B RAF KINASE; DNA GLYCOSYLASE MUTY;

ADENOMATOUS POLYP; CANCER DIAGNOSIS; CELL LINEAGE; CIGARETTE SMOKING; CLINICAL FEATURE; COLORECTAL TUMOR; CYTOLOGY; DISEASE COURSE; EPIGENETICS; FAMILIAL COLON POLYPOSIS; GENE MUTATION; HEREDITARY COLORECTAL CANCER; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; MISMATCH REPAIR; MOLECULAR PATHOLOGY; MULTIGENE FAMILY; NERVE CELL PLASTICITY; PEDIGREE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; TUMOR CELL; TUMOR CLASSIFICATION;

ADENOMA; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE;

EID: 77950618176     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.10.16     Document Type: Review

References (74)

1. Boland CR, Thibodeau SN, Hamilton SR et al.: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58, 5248-5257 (1998).
2. Rodriguez-Bigas MA, Boland CR, Hamilton SR et al.: A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J. Natl Cancer Inst. 89, 1758-1762 (1997).
3. Jass JR, Cottier DS, Jeevaratnam P et al.: Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer. Lancet 346, 1200-1201 (1995).
4. Jass JR, Pokos V, Arnold JL et al.: Colorectal neoplasms detected colonoscopically in at-risk members of colorectal cancer families stratified by the demonstration of DNA microsatellite instability. J. Mol. Med. 74, 547-551 (1996).
5. Castells A, Castellvi-Bel S, Balaguer F: Concepts in familial colorectal cancer: where do we stand and what is the future? Gastroenterology 137, 404-409 (2009).
6. Lindor NM, Rabe K, Petersen GM et al.: Lower cancer incidence in Amsterdam I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293, 1979-1985 (2005).
7. Jeevaratnam P, Cottier DS, Browett PJ, Van De Water NS, Pokos V, Jass JR: Familial giant hyperplastic polyposis predisposing to colorectal cancer: a new hereditary bowel cancer syndrome. J. Pathol. 179, 20-25 (1996).
8. Jass JR: Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J. Gastroenterol. 12, 4943-4950 (2006).
9. Lynch HT, Lynch JF, Lynch PM: Toward a consensus in molecular diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome). J. Natl Cancer Inst. 99, 261-263 (2007).
10. Llor X, Pons E, Xicola RM et al.: Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway. Clin. Cancer Res. 11, 7304-7310 (2005).
11. Pendergrass C: Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study. Clin. Gastroenterol. Hepatol. 6, 1011-1015 (2008).
12. Bengoechea O, Martinez-Penuela JM, Larrinaga B, Valerdi J, Borda F: Hyperplastic polyposis of the colorectum and adenocarcinoma in a 24-year-old man. Am. J. Surg. Pathol. 11, 323-327 (1987).
13. Cohen SM, Brown L, Janower ML, McCready FJ: Multiple metaplastic (hyperplastic) polyposis of the colon. Gastrointest. Radiol. 6, 333-335 (1981). (Pubitemid 12232236)
14. Keljo DJ, Weinberg AG, Winick N, Tomlinson G: Rectal cancer in an 11-year-old girl with hyperplastic polyposis. J. Pediatr. Gastroenterol. Nutr. 28, 327-332 (1999). (Pubitemid 29293660)
15. Torlakovic E, Snover DC: Serrated adenomatous polyposis in humans. Gastroenterology 110, 748-755 (1996). (Pubitemid 26071842)
16. Leggett BA, Devereaux B, Biden K, Searle J, Young J, Jass J: Hyperplastic polyposis: association with colorectal cancer. Am. J. Surg. Pathol. 25, 177-184 (2001). (Pubitemid 32167499)
17. Rubio CA, Stemme S, Jaramillo E, Lindblom A: Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy 38, 266-270 (2006).
18. Yeoman A, Young J, Arnold J, Jass J, Parry S: Hyperplastic polyposis in the New Zealand population: a condition associated with increased colorectal cancer risk and European ancestry. NZ Med. J. 120, U2827 (2007).
19. Carvajal-Carmona LG, Howarth KM, Lockett M et al.: Molecular classification and genetic pathways in hyperplastic polyposis syndrome. J. Pathol. 212, 378-385 (2007). (Pubitemid 47099014)
20. English DR, Young JP, Simpson JA et al.: Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype. Cancer Epidemiol. Biomarkers Prev. 17, 1774-1780 (2008).
21. Wallace K, Grau MV, Ahnen D et al.: The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol. Biomarkers Prev. 18, 2310-2317 (2009).
22. Ji BT, Weissfeld JL, Chow WH, Huang WY, Schoen RE, Hayes RB: Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol. Biomarkers Prev. 15, 897-901 (2006). (Pubitemid 43823515)
23. Morimoto L, Newcomb P, Ulrich C et al.: Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol. Biomarkers Prev. 11, 1012-1018 (2002). (Pubitemid 35192651)
24. Shrubsole MJ, Wu H, Ness RM, Shyr Y, Smalley WE, Zheng W: Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps. Am. J. Epidemiol. 167(9), 1050-1058 (2008). (Pubitemid 351601236)
25. Minoo P, Baker K, Goswami R et al.: Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 55, 1467-1474 (2006). (Pubitemid 44476793)
26. Spjut H, Estrada RG: The significance of epithelial polyps of the large bowel. Pathol. Annu. 12(Pt 1), 147-170 (1977). (Pubitemid 8230738)
27. Burt R, Jass JR: Hyperplastic polyposis. In: Pathology and Genetics of Tumours of the Digestive System. Hamilton SR, Aaltonen LA (Eds). IARC Press, Lyon, France, 135-136 (2000).
28. Williams GT, Arthur JF, Bussey HJ, Morson BC: Metaplastic polyps and polyposis of the colorectum. Histopathology 4, 155-170 (1980).
29. Jass JR: Gastrointestinal polyposes: clinical, pathological and molecular features. Gastroenterol. Clin. North Am. 36, 927-946, viii (2007). (Pubitemid 350051706)
30. Jass JR: Colorectal polyposes: from phenotype to diagnosis. Pathol. Res. Pract. 204, 431-447 (2008).
31. Chow E, Lipton L, Lynch E et al.: Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 131, 30-39 (2006). (Pubitemid 44015745)
32. Ferrandez A, Samowitz W, DiSario JA, Burt RW: Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am. J. Gastroenterol. 99, 2012-2018 (2004). (Pubitemid 39421248)
33. Hyman NH, Anderson P, Blasyk H: Hyperplastic polyposis and the risk of colorectal cancer. Dis. Colon Rectum 47, 2101-2104 (2004). (Pubitemid 40179073)
34. Lage P, Cravo M, Sousa R et al.: Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study. Am. J. Gastroenterol. 99, 1779-1784 (2004). (Pubitemid 39237508)
35. Place RJ, Simmang CL: Hyperplastic-adenomatous polyposis syndrome. J. Am. Coll. Surg. 188, 503-507 (1999).
36. Rashid A, Houlihan PS, Booker S, Petersen GM, Giardiello FM, Hamilton SR: Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 119, 323-332 (2000). (Pubitemid 30621982)
37. Renaut AJ, Douglas PR, Newstead GL: Hyperplastic polyposis of the colon and rectum. Colorectal Dis. 4, 213-215 (2002).
38. Boparai KS, Mathus-Vliegen EM, Koornstra JJ et al.: Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut DOI: 10.1136/gut.2009.185884 (2009) (Epub ahead of print).
39. Jass JR, Cottier DS, Pokos V, Parry S, Winship IM: Mixed epithelial polyps in association with hereditary non-polyposis colorectal cancer providing an alternative pathway of cancer histogenesis. Pathology 29, 28-33 (1997). (Pubitemid 27135824)
40. Vandrovcova J, Lagerstedt-Robinsson K, Pahlman L, Lindblom A: Somatic BRAF-V600E mutations in familial colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 15, 2270-2273 (2006). (Pubitemid 44877055)
41. Azimuddin K, Stasik JJ, Khubchandani IT, Rosen L, Riether RD, Scarlatto M: Hyperplastic polyps: "more than meets the eye"? Report of sixteen cases. Dis. Colon Rectum 43, 1309-1313 (2000).
42. East JE, Saunders BP, Jass JR: Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol. Clin. North Am. 37, 25-46, v (2008).
43. Young J, Barker MA, Simms LA et al.: Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. Clin. Gastroenterol. Hepatol. 3, 254-263 (2005). (Pubitemid 40568731)
44. Yantiss RK, Goodarzi M, Zhou XK et al.: Clinical, pathologic, and molecular features of early-onset colorectal carcinoma. Am. J. Surg. Pathol. 33, 572-582 (2009).
45. O'Brien MJ, Yang S, Mack C et al.: Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am. J. Surg. Pathol. 30, 1491-1501 (2006). (Pubitemid 44808785)
46. Cooper HS, Patchefsky AS, Marks G: Adenomatous and carcinomatous changes within hyperplastic colonic epithelium. Dis. Colon Rectum 22, 152-156 (1979). (Pubitemid 9196208)
47. McCann BG: A case of metaplastic polyposis of the colon associated with focal adenomatous change and metachronous adenocarcinomas. Histopathology 13, 700-702 (1988).
48. Sumner HW, Wasserman NF, McClain CJ: Giant hyperplastic polyposis of the colon. Dig. Dis. Sci. 26, 85-89 (1981).
49. Spring KJ, Zhao ZZ, Karamatic R et al.: High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 131, 1400-1407 (2006). (Pubitemid 44708940)
50. Beach R, Chan AO, Wu TT et al.: BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am. J. Pathol. 166, 1069-1075 (2005). (Pubitemid 40524431)
51. Yuen ST, Davies H, Chan TL et al.: Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res. 62, 6451-6455 (2002). (Pubitemid 35364105)
52. O'Brien MJ, Yang S, Clebanoff JL et al.: Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-RAS mutation to location and histologic subtype. Am. J. Surg. Pathol. 28, 423-434 (2004). (Pubitemid 38436515)
53. Boparai KS, Dekker E, Van Eeden S et al.: Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology 135, 2014-2018 (2008).
54. Vogelstein B, Fearon ER, Hamilton SR et al.: Genetic alterations during colorectal-tumor development. N. Engl J. Med. 319, 525-532 (1988).
55. Weisenberger DJ, Siegmund KD, Campan M et al.: CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat. Genet. 38, 787-793 (2006). (Pubitemid 43980599)
56. Wynter CV, Walsh MD, Higuchi T, Leggett BA, Young J, Jass JR: Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer. Gut 53, 573-580 (2004). (Pubitemid 38372984)
57. Buchanan D, Young J: A perspective on bi-allelic MUTYH mutations in patients with hyperplastic polyposis syndrome. Gastroenterology 136(7), 2407-2408 (2009).
58. Parry S, Woodall S, Walsh M et al.: Surveillance recommendations for individuals with MUTYH-associated polyposis and hyperplastic polyps: the dilemma. Presented at: InSiGHT Meeting. Dusseldorf, Germany, 23-27 June (2009).
59. Jarrar A, Church JM, Fay S, Kalady M: Is the phenotype mixed or mistaken? Hereditary nonpolyposis colorectal cancer and hyperplastic polyposis syndrome. Dis. Colon Rectum 52(12), 1949-1955 (2009).
60. Walsh MD, Buchanan DD, Walters R et al.: Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis. Fam. Cancer 8(4), 313-323 (2009).
61. Loughrey MB, Waring PM, Tan A et al.: Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Fam. Cancer 6, 301-310 (2007). (Pubitemid 47175009)
62. Lagerstedt Robinson K, Liu T, Vandrovcova J et al.: Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J. Natl Cancer Inst. 99, 291-299 (2007). (Pubitemid 47073492)
63. Ang PW, Li WQ, Soong R, Iacopetta B: BRAF mutation is associated with the CpG island methylator phenotype in colorectal cancer from young patients. Cancer Lett. 273, 221-224 (2009).
64. Samowitz WS, Sweeney C, Herrick J et al.: Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res. 65, 6063-6069 (2005).
65. Jasperson KW, Blazer KR, Lowstuter K, Weitzel JN: Working through a diagnostic challenge: colonic polyposis, Amsterdam criteria, and a mismatch repair mutation. Fam. Cancer 7(4), 281-285 (2008).
66. Lipkin SM, Afrasiabi K: Familial colorectal cancer syndrome X. Semin. Oncol. 34, 425-427 (2007).
67. Jass JR, Walsh MD, Barker M, Simms LA, Young J, Leggett BA: Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability. Eur. J. Cancer 38, 858-866 (2002).
68. Iino H, Simms L, Young J et al.: DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer. Gut 47, 37-42 (2000).
69. Young J, Simms LA, Biden KG et al.: Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am. J. Pathol. 159, 2107-2116 (2001).
70. Dunlop MG, Farrington SM: MUTYH-associated polyposis and colorectal cancer. Surg. Oncol. Clin. N. Am. 18, 599-610 (2009).
71. Jass JR, Iino H, Ruszkiewicz A et al.: Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut 47, 43-49 (2000).
72. Iino H, Jass JR, Simms LA et al.: DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J. Clin. Pathol. 52, 5-9 (1999).
73. Colebatch A, Hitchins M, Williams R, Meagher A, Hawkins NJ, Ward RL: The role of MYH and microsatellite instability in the development of sporadic colorectal cancer. Br. J. Cancer 95, 1239-1243 (2006).
74. Kambara T, Simms LA, Whitehall VL et al.: BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53, 1137-1144 (2004).